4-aminopyridine decreases mptp-induced behavioral disturbances in animal model of parkinson’s disease
نویسندگان
چکیده
background and purpose: progressive degeneration of dopaminergic neurons in the midbrain is the main mechanism of parkinson’s disease (pd). although potassium channels affect neural activity and death in this area, little research has investigated the effect of potassium channel blockers, such as 4-aminopyridine in the pretreatment of pd. methods: fifty-six healthy male wistar rats were selected for this study. they were divided into seven groups according to receiving saline or 4-aminopyridine, receiving a low or high dose of 4-aminopyridine and receiving 4-aminopyridine for short or long periods. apomorphine-induced rotational test, elevated body swing test and rotarod test were done to examine behavioral performances. results: 4-aminopyridine could not completely block behavioral disturbances induced by mptp, however, it decreased them in all behavioral tests. long administration of 4-aminopyridine was more effective than short administration in lowering behavioral disturbances. although high dose of 4-aminopyridine was more effective than low dose in initial trials of each behavioral test, there was no difference between them in the last trial. conclusion: long administration of low dose of 4-aminopyridine is the best way to lessen behavioral disturbances induce by mptp and also avoiding side effects of high dose of 4-aminopyridine.
منابع مشابه
4-Aminopyridine Decreases MPTP-Induced Behavioral Disturbances in Animal Model of Parkinson’s Disease
Background and purpose: Progressive degeneration of dopaminergic neurons in the midbrain is the main mechanism of Parkinson’s disease (PD). Although potassium channels affect neural activity and death in this area, little research has investigated the effect of potassium channel blockers, such as 4-aminopyridine in the pretreatment of PD. Methods: Fifty-six healthy male Wistar rats were selecte...
متن کاملceftriaxone decreases mptp-induced behavioral disturbances in animal model of parkinson’s disease
background and purpose: progressive degeneration of dopaminergic neurons in the midbrain is the main mechanism of parkinson’s disease (pd). recent studies have shown ceftriaxone, a β-lactam antibiotic, to be a neuroprotective in various neurodegenerative disorders. hence, the present study aimed to investigate the effect of ceftriaxone on behavioral disturbances of pd in an animal model. method...
متن کاملArbutin attenuates behavioral impairment and oxidative stress in an animal model of Parkinson's disease
Objective: Arbutin has been shown to have antioxidant and free-radical scavenging properties. The aim of this study was to investigate the effects of arbutin administration on behavioral impairment, and oxidative and nitrosative stress in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)-induced animal model of Parkinson’s disease (PD). Materials and Methods: PD model was developed by 4 int...
متن کاملMotor disturbances and thalamic electrical power of frequency bands' improve by grape seed extract in animal model of Parkinson's disease
Objective: Previous studies showed that grape seed extract (GSE) is an excellent natural substance with potent antioxidant effect and free radical scavenger. This study aimed to evaluate the effect of GSE on motor dysfunctions and thalamic local Electroencephalography (EEG) frequency bands' powers in rats with Parkinson's disease (PD). Materials and Methods: In this study 8 µg 6-hydroxydopamin...
متن کاملBehavioral disturbances in Parkinson's disease
Treatment of Parkinson's disease (PD) is complex and often involves addressing behavioral changes in addition to the movement disorder. Patients with PD are susceptible to any psychiatric condition seen in the general population; some disorders, such as depression and anxiety, may result from PD-related neuropathological changes. Medicationrelated hallucinations are seen in many PD patients who...
متن کاملRole of Exercise and Gdnf in an Animal Model of Parkinsons Disease: Implications for Neuroprotection
Parkinson's disease (PD) is a progressive neurodegenerative disorder resulting in part from loss of nigrostriatal dopamine (DA) neurons. Treatments act only to relieve symptoms. It is therefore essential to develop treatments that slow or reverse the neurodegenerative process. Here, I explored exercise as a potential treatment against a 6-hydroxydopamine (6-OHDA) rat model. 6-OHDA causes select...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
international clinical neurosciences journalجلد ۲، شماره ۴، صفحات ۱۴۲-۱۴۶
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023